Molecular mechanisms of thrombolysis: Implications for therapy
- 15 July 1990
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 40 (2) , 177-186
- https://doi.org/10.1016/0006-2952(90)90676-c
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- New strategies in the development of thrombolytic agentsAnnals of Hematology, 1988
- Streptokinase - Biochemistry and Clinical ApplicationEnzyme, 1988
- Thrombolytic TherapyAnnual Review of Medicine, 1988
- Anisoylated Plasminogen Streptokinase Activator Complex (APSAC)Drugs, 1987
- Intravenous Anisoylated Plasminogen Streptokinase Activator Complex versus Intravenous Streptokinase in Evolving Myocardial InfarctionDrugs, 1987
- Human tissue-type plasminogen activator: from the laboratory to the bedside.Circulation, 1985
- Thrombolytic therapy in patients with acute myocardial infarction.Circulation, 1985
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983
- Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapyNature, 1981
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980